Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.37, $0.30 better than the analyst estimate of $0.07. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $298.16 million.

GUIDANCE:

Exelixis sees FY2021 revenue of $1.3-1.4 billion, versus the consensus of $1.23 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.